Leading the development of a rapid and portable electrochemical biosensor for real-time tracking of sepsis through biomarker quantification, aimed at improving point-of-care diagnostic capabilities
Engineered an electrochemical assay for early onsite detection of Melioidosis, integrating field-deployable diagnostics with clinical utility
Authored and reviewed technical reports, experimental protocols, and quality-controlled documentation for research, testing, and operational processes in compliance with regulatory standards
Diagnosed and resolved technical and operational challenges in sensor function and assay reproducibility, ensuring robustness and continuity of field instrumentation
Supervised and mentored undergraduate, master’s, and Ph.D. students in biosensor design, assay development, data interpretation, and good laboratory practices
Maintained and calibrated field equipment, troubleshooting instrumentation to ensure optimal performance during extended field deployments
Led the development of the CoST sensor, an electrochemical point-of-care diagnostic platform for stratifying COVID-19 severity based on multiplexed cytokine profiling.
Designed and validated an electrochemical immunoassay for early detection of melioidosis via capsular polysaccharide (CPS) quantification, integrating sensor design with IRB-approved human sample testing.
Authored research protocols for sensor manufacturing, electrochemical measurements, and clinical study workflows under GLP/GCP standards.
Developed and optimized instrumentation workflows for assay reproducibility and device reliability across multiple use cases.
Supervised and mentored undergraduate students in experimental design, materials handling, data interpretation, and biosensor fabrication techniques.
Resolved data inconsistencies through rigorous quality checks and statistical validation to ensure high integrity assay results and reproducible sensor outputs
Developed boron-doped diamond (BDD) electrodes for electrochemical detection of anticancer drugs, contributing to advancements in implantable and minimally invasive sensing platforms.
Engineered an implantable drug-sensing system aimed at monitoring antiepileptic drug levels in vivo, to support personalized and safe therapeutic strategies.
Conducted comprehensive literature reviews to stay abreast of developments in electrochemical sensing and pharmacokinetics, informing experimental design and innovation.
Ensured compliance with international standards for data collection, experimental protocol documentation, and research reproducibility.
Actively engaged in collaborative research discussions and progress reviews with external institutional and industrial partners.
Authored and contributed to multiple peer-reviewed journal publications, including drafting experimental sections and coordinating with co-authors on interdisciplinary manuscripts.